First At-Home Gluten Consumption Monitoring Test Launched by Glutenostics

[junkie-button url=”http://infomeddnews.com/” style=”grey” size=”medium” type=”round” target=”_blank”] HOME [/junkie-button]

The company reports that in just 15 minutes or more, in the privacy of a bathroom anywhere in the world, people are now able to sample their urine or stool to detect gluten fragments indicative of gluten consumption over the previous 1-2 or more days.  “This revolutionary and one-of-a-kind technology will empower people to take control of their gluten-free life and improve adherence to the diet through scientifically informed decision making,” states David Winternheimer, PhD, CEO of Glutenostics.  “Whatever your motive for maintaining gluten-free living, Gluten Detective is a flexible monitoring tool to provide valuable insight into your dietary composition, and afford users peace of mind.”

The technology basis of Gluten Detective was developed by a company in Seville, Spain (Biomedal), where over a decade of research and development was invested in the innovation of these game-changing products.  As an integral part of the worldwide roll-out of both lab- and home-based testing products for gluten, Glutenostics is responsible for the commercialization of these tests in the USA and Canada, where they are the exclusive licensee and distributor of the technology.

Dr. Winternheimer added, “Glutenostics is transforming the way people live gluten-free,” both with these novel tests and assessment of future product opportunities in our pipeline.”  In collaboration with industry-leading key opinion leaders and non-profit partners, Glutenostics is working to change the landscape of the gluten-free space.  He added, “Today we are also proud to announce our new investor, cited as the most successful biotech entrepreneur in Germany, Patrick Baeuerle.  With our outstanding team of advisors, executives and partners, we are optimistic of Glutenostics’ ability to positively impact the gluten-free community.”